A man with recurrent hypovolemic shock on anti-programmed cell death protein 1 treatment: Immune-related protein-losing enteropathy

被引：3
|
作者：
Lee, Seo Young [1 ]
Kim, Min Hwan [1 ]
Jang, Mi [2 ]
Park, Yehyun [3 ]
Cho, Byoung Chul [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 104卷
关键词：
D O I：
10.1016/j.ejca.2018.09.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：104 / 107
页数：4
相关论文
共 50 条
  • [41] Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer
    Ono, Kana
    Ono, Hirotaka
    Toi, Yukihiro
    Sugisaka, Jun
    Aso, Mari
    Saito, Ryohei
    Kawana, Sachiko
    Aiba, Tomoiki
    Odaka, Tetsuo
    Matsuda, Suguru
    Saito, Shin
    Narumi, Akane
    Ogasawara, Takahiro
    Shimizu, Hisashi
    Domeki, Yutaka
    Terayama, Keisuke
    Kawashima, Yosuke
    Nakamura, Atsushi
    Yamanda, Shinsuke
    Kimura, Yuichiro
    Honda, Yoshihiro
    Sugawara, Shunichi
    CANCER MEDICINE, 2021, 10 (14): : 4796 - 4804
  • [42] Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Shimoda, Yukiko
    Md, Daisuke Takayanagi
    Shiraishi, Kouya
    Kubo, Takashi
    Mitani, Sachiyo
    Md, Yuji Matsumoto
    Masuda, Ken
    Md, Yuki Shinno
    Md, Yusuke Okuma
    Md, Yasushi Goto
    Md, Hidehito Horinouchi
    Ichikawa, Hitoshi
    Kohno, Takashi
    Md, Noboru Yamamoto
    Md, Shingo Matsumoto
    Md, Koichi Goto
    Md, Shun-ichi Watanabe
    Md, Yuichiro Ohe
    Md, Noriko Motoi
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (12) : 2078 - 2090
  • [43] Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy
    Pradere, P.
    Michot, J. M.
    Champiat, S.
    Danlos, F. X.
    Marabelle, A.
    Lambotte, O.
    Albiges, L.
    Le Pavec, J.
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 308 - 309
  • [44] Combination of cytokine-directed and anti-programmed cell death protein 1 therapy - a new attractive option in melanoma treatment?
    Urbonas, Vincas
    Smailyte, Giedre
    MELANOMA RESEARCH, 2018, 28 (05) : 469 - 470
  • [45] Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies
    Hwang, Shelley J. E.
    Carlos, Giuliana
    Chou, Shaun
    Wakade, Deepal
    Carlino, Matteo S.
    Fernandez-Penas, Pablo
    MELANOMA RESEARCH, 2016, 26 (04) : 413 - 416
  • [46] Post-shingles granulomatous dermatosis related to anti-programmed cell death 1
    Assi, Tarek
    Danu, Alina
    Mateus, Christine
    Robert, Caroline
    Michot, Jean-Marie
    Ibrahim, Tony
    Lazarovici, Julien
    Ghezl, David
    Rossignol, Julien
    Dartigues, Peggy
    Terroir-Cassou-Mounat, Marie
    Ribrag, Vincent
    IMMUNOTHERAPY, 2019, 11 (07) : 591 - 598
  • [47] Rheumatological Immune Related Adverse Events in Malignancy Patients Treated with Anti-Programmed Cell Death (PD) 1 Antibodies
    Mitchell, Emma
    Lau, Peter
    Khoo, Chloe
    Smith, Kortnye
    Brady, Benjamin
    Shackleton, Mark
    McArthur, Grant
    Wicks, Ian
    Sandhu, Shahneen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [48] Association between programmed death protein 1-related single-nucleotide polymorphisms and immune-related adverse events induced by programmed death protein 1 inhibitors-a pilot study
    Cai, Linxuan
    Lyu, Ziyan
    Zhang, Yuan
    Xie, Ke
    Chen, Min
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [49] Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia
    Choi, Min Chul
    Oh, Jisu
    Lee, Chan
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 94 - 97
  • [50] Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events
    Wijn, Dirk H.
    Groeneveld, Geert H.
    Vollaard, Albert M.
    Muller, Mirte
    Wallinga, Jacco
    Gelderblom, Hans
    Smit, Egbert F.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 182 - 187
12345